Physician profile
Mike Labenz
NPI 1386699643
$481.73
in general payments reported to CMS, 2019-2025
10 companies · $29.15 in 2025
The $29.15 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.60 · 2021: $26.17 · 2022: $115 · 2023: $212 · 2024: $40.05 · 2025: $29.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $281.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $119.09 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Progenics Pharmaceuticals, INC. | $81.26 | 2023 | Pylarify |
| Penumbra, INC. | $76.36 | 2023 | Ruby Coil |
| Ge Healthcare | $58.85 | 2019-2023 | |
| Siemens Medical Solutions USA, INC. | $43.99 | 2019-2023 | Artis Zee Multi-Purpose |
| Mozarc Medical US LLC | $29.15 | 2025 | Pta High Pressure Balloon Dilatation Catheter |
| Terumo Medical Corporation | $26.17 | 2021 | |
| Argon Medical Devices, INC. | $21.20 | 2024 | Clot Management |
| Boston Scientific Corporation | $14.37 | 2022 | |
| Cook Medical LLC | $11.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mike Labenz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.